Eshallgo Inc. - Class A Ordinary Shares (EHGO)

Artificial Intelligence is rapidly transforming drug discovery, clinical research , and Alzheimer's disease development, and IGC Pharma, Inc. (NYSE: IGC) is positioning itself at the forefront of that evolution. The clinical-stage biotechnology company will present seven scientific papers at the Alzheimer's Association International Conference (AAIC) 2026 in London, July 12-15, highlighting a growing portfolio of AI-powered healthcare technologies designed to accelerate Alzheimer's drug development , improve clinical trials , and enhance precision medicine .

Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) continues to accelerate commercialization after reporting record June 2026 sales orders, completing its Generation 2.0 Graphene Manufacturing Plant , and approving the next phase of manufacturing expansion.

Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) continues to build momentum as the company expands production, secures new commercial partnerships, and advances the commercialization of its graphene technology platform. Founder and CEO Craig Nicol recently appeared on CEO.CA to discuss GMG's growing ability to manufacture and sell its expanding portfolio of graphene-based products. Watch the interview Now!

Small-cap stocks continue attracting investor interest as companies across the AI infrastructure, digital transformation, environmental technology, and entertainment sectors announce significant developments that could position them for future growth. Among the companies currently drawing attention are Sphere 3D Corp. (NASDAQ: ANY), IceCure Medical Ltd. (NASDAQ: ICCM), Eshallgo Inc. (NASDAQ: EHGO), Euro Tech Holdings Company Limited (NASDAQ: CLWT), and Kartoon Studios Inc. (NYSE: TOON).